tissue (MALT) in 16 patients together with treatment and outcome was undertaken. Immunohistochemical studies of fresh tissue easily distinguished MALT lymphoma from benign reactive lymphoid hyperplasia (pseudolymphoma) and showed that tumour cells had the characteristic phenotype indicative of their origin from MALT. Persistant epigastric pain was the main presenting complaint, and was often associated with acute bleeding, anaemia, or weight loss. Eight patients had a past history of recurrent peptic ulcers or gastritis. The endoscopic appearance suggested malignancy in only half the cases and was compatible with gastritis or a benign peptic ulcer in the remainder. There was extragastric involvement of other mucosal sites in eight patients (mainly the lung, but also the parotid gland and small bowel), but rarely was bone marrow and never the spleen or peripheral lymph nodes affected. Conservative treatment with long term cyclophosphamide was effective in both stage I and stage IV disease, and all the patients are alive after a median follow up of 4.5 years. These findings confirm that low grade gastric MALT lymphomas are usually indolent tumours with non-specific endoscopic aspects and show that dissemination to other mucosal sites was Round opacity of 5 cm in left lung 16 Bilateral opacities with diffuse shadowing + lung lymphoma and responded to chemotherapy as well as the gastric lesion. The macroscopic aspect of the lung involvement is described in Table IV . Gastric endosonography, performed in patient 9, who had thickening of gastric folds in the body and the antrum at endoscopy (Table  II) , showed massive infiltration of the gastric wall together with perigastric lymph node enlargement.
TREATMENT AND OUTCOME The eight patients with stage IV disease received cyclophosphamide. All these patients are alive after a follow up ranging from 1 to 7X5 years. Four are in a first complete remission and one in partial remission. Three relapsed at 6 years (n=2) and 7 years (n= 1). One of these latter patients (no 13) was operated on for an obstructive small bowel relapse and in this patient, as in the two others, gastroscopy and chest computed tomography showed both lung and gastric recurrences. All three patients who relapsed responded again to cyclophosphamide. Repeated gastric biopsies did not show progression to a higher grade lymphoma in any of the patients.
Chemotherapy was well tolerated and no cases of myelodysplastic syndromes were observed despite follow up exceeding two years in seven patients treated with alkylating agents.
Discussion
All the patients we studied fulfilled the histological and immunocytological criteria established by Isaacson The clinical presentation of our patients confirmed previous reports of the non-specific nature of digestive symptoms, clinical indolence, and the slow course in low grade gastric MALT lymphoma.'2 '3 All the patients had complained of chronic epigastric pain for years before diagnosis and eight had a past history of recurrent gastric ulcer, gastrointestinal bleeding, or gastritis. The endoscopic aspect of the gastric lesions was clearly suggestive of malignancy in only half the patients. In the remaining cases, the endoscopist described erythematous gastritis, small nodules or thickening and erosions of gastric folds suggestive of a benign condition. This explains how the disease can be misdiagnosed over a long period and stresses the need for biopsy specimens whatever the type of gastric lesion. In patient 9, endosonography showed that there was no relationship between the endoscopic aspect and the locoregional extension of the lymphoma. Although the endoscopic changes were minimal (only mild thickening of gastric folds), endosonography disclosed massive infiltration of the gastric wall associated with an enlargement of regional lymph nodes. This observation illustrates the usefulness of endosonography in the staging of low grade gastric lymphoma.2'
The chronic nature of the symptoms, the benign appearance of the gastric lesions on endoscopy, and the equivocal histological aspect of the lesions account for the fact that numerous MALT lymphomas were considered 'pseudolymphomas'47 until the monoclonal nature of the proliferation could be routinely shown by immunochemistry. In our series, two patients (nos 3 and 9) were diagnosed as having pseudolymphomas 3 and 10 years respectively before the diagnosis of MALT lymphoma. In both cases a review of previous biopsy specimens showed the presence of lympho-epithelial lesions clearly indicative of malignancy."522 This typical lesion was also present on the surgical specimen from patient 10 were susceptible to spread to or to recur in other mucosal sites.'32425 Although the exact frequency of extragastric localisation remains to be determined prospectively in a larger series, our observations suggest that this possibility has to be taken into account in the choice of the staging procedure and therapeutic strategy.
In previously published studies, most authors recommended surgery, arguing that low grade gastric MALT lymphomas were localised, solitary lesions that could be excised completely467'324 and that endoscopic biopsy specimens could miss small foci of high grade, B cell lymphomas.26 However, in our series half the patients had a stage IV lymphoma. Among the eight with stage I disease, five had tumoural involvement of the stomach which would have required total gastrectomy, a procedure with a high morbidity rate and one that is not justified with a well tolerated, slowly progressing disease. Moreover, in one patient (no 10), the lymphoma relapsed after partial gastrectomy. We therefore favoured conservative treatment with cyclophosphamide monochemotherapy.
All the patients with stage I disease responded to therapy, and a complete remission was obtained in those (n=4) treated for at least one year. In the eight stage IV patients in whom the follow up was of specially long duration (median 6 years), a complete remission was initially obtained with cyclophosphamide in every case and patients whose disease recurred several years after the initial treatment remained sensitive to monochemotherapy. Moreover, in contrast with a recent report,25 no cases of conversion to a high grade lymphoma were observed. Although cyclophosphamide was well tolerated in our patients, the risk of developing a myelodysplastic syndrome cannot be excluded. However, this long term toxicity of alkylating agents has been shown to be related to the intensity of therapy given27 and is very unlikely to occur with the low doses needed to treat our patients. Thus, in our experience, monochemotherapy is appropriate for low grade, gastric MALT lymphomas.
In conclusion, our findings show that low grade, gastric MALT lymphoma can always be diagnosed on the basis of both fixed and fresh endoscopic biopsy specimens. Extragastric involvement seems to be frequent, usually affecting other mucosal sites and particularly the lung. 
